Institut Català de la Salut
[de Las Heras B] Covance Inc., Princeton, NJ, USA. Madrid Medical Doctors Association, Madrid, Spain. [Saini KS] Covance Inc., Princeton, NJ, USA. East Suffolk and North Essex NHS Foundation Trust, Ipswich, UK. [Boyle F] Mater Hospital, Sydney, Australia. [Ades F] Hospital Alemão Oswaldo Cruz, São Paulo, Brazil. [de Azambuja E] Institut Jules Bordet, Brussels, Belgium. Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. [Bozovic-Spasojevic I] Institute for Oncology and Radiology of Serbia, Belgrade, Serbia. [Capelan M] Vall d'Hebron Hospital Universitari, Barcelona, Spain
Vall d'Hebron Barcelona Hospital Campus
2021-11-05T11:36:58Z
2021-11-05T11:36:58Z
2020-12
Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Càncer; Immuno-oncologia
Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Cáncer; Inmuno-oncología
Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Cancer; Immuno-oncology
The coronavirus disease-2019 (COVID-19) pandemic has had a significant impact on patients with underlying malignancy. In this article, we summarize emerging data related to patients with cancer and COVID-19. Among patients with COVID-19, a higher proportion have an underlying diagnosis of cancer than seen in the general population. Also, patients with malignancy are likely to be more vulnerable than the general population to contracting COVID-19. Mortality is significantly higher in patients with both cancer and COVID-19 compared with the overall COVID-19-positive population. The early months of the pandemic saw a decrease in cancer screening and diagnosis, as well as postponement of standard treatments, which could lead to excess deaths from cancer in the future.
No funding was received from any source. No Rapid Service Fee was received by the journal for the publication of this article.
Article
Published version
English
Càncer - Tractament; COVID-19 (Malaltia); DISEASES::Neoplasms; Other subheadings::Other subheadings::/therapy; DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Therapies, Investigational; ENFERMEDADES::neoplasias; Otros calificadores::Otros calificadores::/terapia; ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::tratamientos en investigación
Springer
Oncology And Therapy;8
https://doi.org/10.1007/s40487-020-00124-2
Attribution-NonCommercial 4.0 International
http://creativecommons.org/licenses/by-nc/4.0/
Articles científics - HVH [3439]